Collectively our data supports that the p32 plays a critical role in melanoma progression in both murine and human cells by repression of various EMT markers and oncogenes via Akt/PKB pathway which is known to alter EMT markers and oncogenes in other cancers [44, 45]. The gene discussed is AKT1; the disease is cancer.